WSO BEAT STROKE Initiative
Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Sep 18, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The WSO BEAT STROKE Initiative is a clinical trial aimed at improving how we prevent strokes in patients who have already had one. Specifically, this study will test a new educational tool designed to help doctors and healthcare providers follow the best practices for preventing future strokes, particularly those caused by heart issues. The trial will include patients aged 65 to 74 who have experienced a type of stroke or a transient ischemic attack (TIA), which is often called a "mini-stroke."
If you or a family member are eligible to participate, you can expect to be part of a group that will receive information and support to help manage your health and reduce the risk of another stroke. The trial is currently not recruiting participants, so it’s still in the planning phase. This initiative is important because it aims to develop better strategies for stroke prevention based on the latest research and guidelines, ultimately helping improve patient care and outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with ischemic stroke or TIA of any etiology.
- Exclusion Criteria:
- • N/A
About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's
The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported